Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Kyle T. Mitchell"'
Autor:
Scott Stanslaski, Rebekah L. S. Summers, Lisa Tonder, Ye Tan, Michelle Case, Robert S. Raike, Nathan Morelli, Todd M. Herrington, Martijn Beudel, Jill L. Ostrem, Simon Little, Leonardo Almeida, Adolfo Ramirez-Zamora, Alfonso Fasano, Travis Hassell, Kyle T. Mitchell, Elena Moro, Michal Gostkowski, Nagaraja Sarangmat, Helen Bronte-Stewart, On behalf of the ADAPT-PD Investigators
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Adaptive deep brain stimulation (aDBS) is an emerging advancement in DBS technology; however, local field potential (LFP) signal rate detection sufficient for aDBS algorithms and the methods to set-up aDBS have yet to be defined. Here we sum
Externí odkaz:
https://doaj.org/article/161691af396044d9900a3ea23ed94dc6
Publikováno v:
npj Parkinson's Disease, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Parkinson’s disease (PD) may optimally be treated with a disease-modifying therapy to slow progression. We compare data underlying surgical approaches proposed to impart disease modification in PD: (1) cell transplantation therapy with ste
Externí odkaz:
https://doaj.org/article/fb91da2a1eee42928b8c6d43c1fb7ecd
Autor:
Caroline M. Tanner, Steven R. Cummings, Michael A. Schwarzschild, Ethan G. Brown, E. Ray Dorsey, Alberto J. Espay, Nicholas B. Galifianakis, Samuel M. Goldman, Irene Litvan, Nijee Luthra, Nikolaus R. McFarland, Kyle T. Mitchell, David G. Standaert, Douglas C. Bauer, Susan L. Greenspan, James C. Beck, Kenneth W. Lyles
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414 ) is a unique collaboration between experts in movement disorders and osteoporosis to test the efficacy of zoledronic acid, an FDA-approve
Externí odkaz:
https://doaj.org/article/de1c2ed76f6f4436af9d6293955c5287
Autor:
Nijee S. Luthra, Kyle T. Mitchell, Monica M. Volz, Idit Tamir, Phillip A. Starr, Jill L. Ostrem
Publikováno v:
Tremor and Other Hyperkinetic Movements, Vol 7 (2017)
Background: Blepharospasm can be present as an isolated dystonia or in conjunction with other forms of cranial dystonia, causing significant disability.Case Report: We report a case of a 69-year-old male with craniocervical dystonia, manifesting prim
Externí odkaz:
https://doaj.org/article/29fc0d8b827b4f18a5cebc1ced1cf2d3
Autor:
Helen Bronte-Stewart, Martijn Beudel, Jill L. Ostrem, Alfonso Fasano, Leonardo Almeida, Travis Hassell, Elena Moro, Michal Gostkowski, Kyle T. Mitchell, Elodie Hainque, Nagaraja Sarangmat, Scott Stanslaski, Lisa Tonder, Rebekah Summers, Robert S. Raike, Todd M. Herrington
Publikováno v:
Sunday, April 23.
Autor:
Ethan G. Brown, Michael A. Schwarzschild, James C. Beck, Kenneth W. Lyles, Caroline M. Tanner, Nikolaus R. McFarland, E. Ray Dorsey, David G. Standaert, Douglas C. Bauer, Irene Litvan, Steven R. Cummings, Nijee Luthra, Nicholas B. Galifianakis, Alberto J. Espay, Samuel M. Goldman, Susan L. Greenspan, Kyle T. Mitchell
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-6 (2021)
NPJ Parkinson's Disease
NPJ Parkinson's disease, vol 7, iss 1
NPJ Parkinson's Disease
NPJ Parkinson's disease, vol 7, iss 1
The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414) is a unique collaboration between experts in movement disorders and osteoporosis to test the efficacy of zoledronic acid, an FDA-approved parenter
Autor:
Prarthana Prakash, Guenther Deuschl, Sarah Ozinga, Kyle T. Mitchell, Binith Cheeran, Paul S. Larson, Aristide Merola, Sergiu Groppa, Tucker Tomlinson, Jill L. Ostrem
Publikováno v:
Movement disorders clinical practice. 9(6)
Despite over 30 years of clinical experience, high-quality studies on the efficacy of bilateral versus unilateral deep brain stimulation (DBS) of the ventral intermediate (VIM) nucleus of the thalamus for medically refractory essential tremor (ET) re
Publikováno v:
NPJ Parkinson's disease. 8(1)
Parkinson's disease (PD) may optimally be treated with a disease-modifying therapy to slow progression. We compare data underlying surgical approaches proposed to impart disease modification in PD: (1) cell transplantation therapy with stem cell-deri
Autor:
Kyle T. Mitchell, Stephen L. Schmidt, Jeffrey W. Cooney, Warren M. Grill, Jennifer Peters, Shervin Rahimpour, Hui-Jie Lee, Sin-Ho Jung, Sneha Mantri, Burton Scott, Shivanand P. Lad, Dennis A. Turner
Publikováno v:
Neurosurgery
Deep brain stimulation (DBS) is an effective therapy in advanced Parkinson disease (PD). Although both subthalamic nucleus (STN) and globus pallidus (GP) DBS show equivalent efficacy in PD, combined stimulation may demonstrate synergism. OBJECTIVE: T